N4 Pharma PLC
N4 Pharma PLC (N4P) is known on LSE - United Kingdom, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerN4P
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Financial periodFY2024
- RevenueGBP 7.28K
- Revenue growth272.9%
- Net income-GBP 1.06M
- Free cash flow-GBP 971.50K
- Gross margin100.0%